1143 / 1816
Conclusions ABC trials
IDFS was significant for superiority of TaxAC relative to TC
4 year OS was high in both groups
Exploratory subgroup analyses suggest TaxAC provides
•
Minimal, if any benefit in ER+/Node negative cohorts
19-9-2017